The clinical relevance of FUBP1 expression in terms of the activation of PTGES and CYP2C19 (a key CYP epoxygenase enzyme in AA metabolism) was further investigated in a group of human osteosarcoma clinical specimens using IHC analysis. Here, CYP2C19 is linked to osteosarcoma.